No Photo Available

Last Update


This profile was last updated on .

Is this you? Claim your profile.

Wrong Earl White?

Mr. Earl L. White

President and Chief Executive Officer

MDx BioAnalytical Laboratory Inc

HQ Phone: (925) 353-7872

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

MDx BioAnalytical Laboratory Inc

5890 Imperial Loop Suite 12

College Station, Texas 77845

United States

Company Description

MDx BioAnalytical Laboratory, Inc. was established in Oro Valley, AZ approximately 20 miles north of Tucson in 2008 and moved to College Station, TX in August of 2010. The Company's strength lies in the background, skills and experiences of it management ... more

Background Information

Employment History

Vice President, Research and Development

iBio , Inc.

Director, Quality Labs

Caliber Biotherapeutics LLC

Vice President of Analytical and Pharmaceutical Sciences

Integrated Biomolecule Corporation

Director, Research and Development

Valor Biotherapeutics LLC

Vice President, Advanced Analytical Sciences

Large Scale Biology Corporation

Director of Quality Control


Senior Staff Scientist and Head of the Mass Spectrometry Group In the Research and Development Department

R.J. Reynolds Tobacco Co.

Managing Director

PDI Analytical

Forensic Toxicologist

Mississippi State Crime Laboratory


Analytical Center of Excellence




Jackson State University

M.S degrees


Jackson State University


analytical chemistry

University of North Carolina at Chapel Hill

Ph.D. degree

analytical chemistry

University of North Carolina at Chapel Hill , NC

Web References (15 Total References)

Al Petrillo/Special to The ... [cached]

Al Petrillo/Special to The Explorer, Earl White, owner of MDx, operates an Agilent 5973N Gas Chromatograph-Mass Spectrometer system.

Al Petrillo/Special to The ... [cached]

Al Petrillo/Special to The Explorer, Earl White, owner of MDx, operates an Agilent 5973N Gas Chromatograph-Mass Spectrometer system.

MDx BioAnalytical is built around the strength of the skills and experience of Earl White, Ph.D, who serves as president and CEO, and his wife, Dorothy, who is managing director.
"We do almost everything that has to do with a pharmaceutical company getting its drug to market," Earl White said, "such as pre-clinical work, characterizing the molecule and stabilities studies to determine how long a drug will last."
White said that MDx also performs pharmacokinetic studies, which examine how a drug behaves in the human body.
"We use a contract research organization that does animal studies on the drug, generally using mice and rats, and then collects tissue samples that we analyze," White noted.
In addition, MDx sets up release assays for pharmaceutical companies in which a drug has already been formulated and is ready for patient use.
"In such a case there might be a clinical trial where we perform assays to determine the identity, purity and concentration of the drug to make sure it meets specifications," White said.
White sees the company's second main focus as the one that has the potential to put MDx on the biotechnological map.
"I helped develop an algorithm to search for biomarkers while I was with a company in California prior to coming to Tucson," White said. "We're in the process of getting access to that algorithm."
Once MDx has that access, White said he can use it to find biomarkers that characterize a patient as diseased or non-diseased.
"We also will be able to project how well a specific treatment might work," he added. "We've submitted for a National Institutes of Health Challenge grant and have formed consortiums with Arizona State University's Biomedical Infomatics Department and the Tufts University dental school in Boston."
White said the algorithm can search biomarkers for any disease, including autoimmune diseases such as Sjogren's Syndrome and Alzheimer's disease.
"It's also been used on multiple sclerosis, ovarian cancer in a study at UCLA, and for prostate and breast cancers," he said.
Before starting MDx BioAnalytical, White served as vice president of analytical and pharmaceutical sciences at Integrated Biomolecule Corporation in Oro Valley. Integrated Biomolecule's lab space off Innovation Park Drive was purchased last November by Ventana Medical Systems, the Roche Holdings-owned diagnostics firm that stands directly across the street. IBC now operates out of other venues, while Ventana uses the lab for its own purposes.
Prior to that, White was vice president of advanced analytical sciences for Large Scale Biology Corp., and its subsidiary, Predictive Diagnostics Inc. Before joining LSBC, he was senior staff scientist and head of the mass spectrometry group in R.J. Reynolds Tobacco Company's research and development department. He began his career as a forensic toxicologist with the Mississippi State Crime Laboratory.
White holds bachelor of science and master of science degrees in chemistry from Jackson State University in Jackson, Miss., and a Ph.D in analytical chemistry from the University of North Carolina at Chapel Hill.

Earl L. White, ... [cached]

Earl L. White, Ph.D.Vice President of Analytical & Pharmaceutical Sciences

Earl received his Ph.D. in Analytical Chemistry - Mass Spectrometry from the University of North Carolina at Chapel Hill and an M.S. in Organic & Analytical Chemistry from Jackson State University.He has published more than 23 peer-reviewed papers and authored more than 37 abstracts and presentations.
Prior to joining IBC, he was Vice President, Advanced Analytical Sciences and Director, Quality Control at Large Scale Biology Corporation and its subsidiary, Predictive Diagnostics, Inc.At Large Scale and PDI he assisted with the successful completion of a Phase 1 Clinical Trial for a Non-Hodgkin's lymphoma vaccine and was a principal investigator in the development of the first patented in silico machine learning technologies and proprietary informatics tools for use with biological samples.

Mr Earl White ... [cached]

Mr Earl White Executive Officer

Predictive Diagnostics, Inc. - Management [cached]

Earl White, Ph.D., Vice President, Advanced Analytical SciencesDr. White joined Predictive Diagnostics' parent company, LSBC, in 1998 as a Sr. Scientist and established the Analytical Center of Excellence.A year later he was promoted to Director of Advanced Analytical Resources and served as Director of Quality Control for LSBC's NHL cancer vaccines program, the Company's first clinical product candidate.In 2002, he was appointed Vice President, Advanced Analytical Sciences, the position in which he currently serves.Prior to joining LSBC, Dr. White was Sr. Staff Scientist and Head of the Mass Spectrometry Group in the Research and Development Department of R.J. Reynolds Tobacco Company from 1985-1998.Dr. White received the B.S. and M.S degrees in chemistry from Jackson State University in Jackson, MS and a Ph.D. degree in analytical chemistry from the University of North Carolina at Chapel Hill, NC where he specialized in mass spectrometry.

Similar Profiles

Other People with this Name

Other people with the name White

Melisa White
Gartner , Inc.

Colin White
Royal Children's Hospital

Amy White
Nike , Inc.

Mark White
Cedar Financial Inc

Elana White

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory